Results 191 to 200 of about 600,809 (212)

Postmarketing Surveillance of Perindopril in Australia

Clinical Drug Investigation, 1996
Perindopril was released on the Australian market in 1992 and was the third angiotensin converting enzyme (ACE) inhibitor to be marketed in this country. A general practice postmarketing surveillance study was undertaken for 12 months in 1191 patients who were prescribed Perindopril to treat hypertension or cardiac failure.
openaire   +2 more sources

Concerns with postmarketing surveillance

American Journal of Health-System Pharmacy, 1984
Michael J. Norvell, Robert J. Anderson
openaire   +3 more sources

Postmarketing safety surveillance of quadrivalent recombinant influenza vaccine: Reports to the vaccine adverse event reporting system.

Vaccine, 2021
E. Woo, P. Moro
semanticscholar   +1 more source

Guidelines on postmarketing surveillance

BMJ, 1988
Bma, Rcgp
openaire   +2 more sources

The safety and effectiveness of remdesivir in a postmarketing surveillance study in Japan.

Respiratory Investigation
Jami Peters, Lindsey Force, Leslie J Ng, Hu Li, Kouji Aoki, Nao Taguchi, Tetsuya Tanikawa, A. Ishizaki   +7 more
semanticscholar   +1 more source

Surveilling Postmarket Surveillance

Biomedical Safety & Standards, 2012
openaire   +2 more sources

Record linkage for postmarketing surveillance

Clinical Pharmacology and Therapeutics, 1989
openaire   +3 more sources

Postmarketing drug surveillance studies

Clinical Pharmacology and Therapeutics, 1991
Gerald A. Faich, Gerald A. Faich
openaire   +3 more sources

Postmarketing surveillance for drug safety

Clinical Pharmacology & Therapeutics, 2004
Linda J. Scarazzini, William L. Holden
openaire   +3 more sources

Safety and efficacy of nivolumab in Japanese patients with malignant melanoma: An interim analysis of a postmarketing surveillance

Journal of dermatology (Print), 2018
Y. Kiyohara, H. Uhara, Y. Ito, N. Matsumoto, T. Tsuchida, N. Yamazaki   +5 more
semanticscholar   +1 more source